Evidence map›Paper›PMID 36094193›Full record

ArticleMicrobiology spectrum2022

Low Diversity and Instability of the Sinus Microbiota over Time in Adults with Cystic Fibrosis.

Catherine R Armbruster, Kelvin Li, Megan R Kiedrowski, Anna C Zemke, Jeffrey A Melvin, John Moore, Samar Atteih, Adam C Fitch, Matthew DuPont, Christopher D Manko and 7 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Differential Evolution ofPathogens (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Elevated glucose increasesInfection and immunity · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. [Advances in next-generation sequencing technology to analyze the microbiome of patients with chronic sinusitis].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2024
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Catherine R ArmbrusterDepartment of Microbiology and Molecular Genetics, University of Pittsburghgrid.412689.0grid.21925.3d School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID 0000-0003-0795-802X
Kelvin LiCenter for Medicine and the Microbiome, University of Pittsburghgrid.412689.0grid.21925.3d and University of Pittsburgh Medical Centergrid.412689.0, Pittsburgh, Pennsylvania, USA.
Megan R KiedrowskiDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Anna C ZemkeDepartment of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburghgrid.412689.0grid.21925.3d School of Medicine, Pittsburgh, Pennsylvania, USA.
Jeffrey A MelvinDepartment of Microbiology and Molecular Genetics, University of Pittsburghgrid.412689.0grid.21925.3d School of Medicine, Pittsburgh, Pennsylvania, USA.
John MooreDepartment of Otolaryngology, University of Pittsburgh Medical Centergrid.412689.0, Pittsburgh, Pennsylvania, USA.
Samar AtteihDepartment of Microbiology and Molecular Genetics, University of Pittsburghgrid.412689.0grid.21925.3d School of Medicine, Pittsburgh, Pennsylvania, USA.
Adam C FitchCenter for Medicine and the Microbiome, University of Pittsburghgrid.412689.0grid.21925.3d and University of Pittsburgh Medical Centergrid.412689.0, Pittsburgh, Pennsylvania, USA.
Matthew DuPontDepartment of Microbiology and Molecular Genetics, University of Pittsburghgrid.412689.0grid.21925.3d School of Medicine, Pittsburgh, Pennsylvania, USA.
Christopher D MankoDepartment of Microbiology and Molecular Genetics, University of Pittsburghgrid.412689.0grid.21925.3d School of Medicine, Pittsburgh, Pennsylvania, USA.
Madison L WeaverDepartment of Microbiology and Molecular Genetics, University of Pittsburghgrid.412689.0grid.21925.3d School of Medicine, Pittsburgh, Pennsylvania, USA.
Jordon R GastonDepartment of Microbiology and Molecular Genetics, University of Pittsburghgrid.412689.0grid.21925.3d School of Medicine, Pittsburgh, Pennsylvania, USA.
John F AlcornDepartment of Pediatrics, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Alison MorrisCenter for Medicine and the Microbiome, University of Pittsburghgrid.412689.0grid.21925.3d and University of Pittsburgh Medical Centergrid.412689.0, Pittsburgh, Pennsylvania, USA.
Barbara A MethéCenter for Medicine and the Microbiome, University of Pittsburghgrid.412689.0grid.21925.3d and University of Pittsburgh Medical Centergrid.412689.0, Pittsburgh, Pennsylvania, USA.
Stella E LeeDepartment of Otolaryngology, University of Pittsburgh Medical Centergrid.412689.0, Pittsburgh, Pennsylvania, USA.
Jennifer M BombergerDepartment of Microbiology and Molecular Genetics, University of Pittsburghgrid.412689.0grid.21925.3d School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID 0000-0003-4767-6238
University of Pittsburgh · USUniversity of Pittsburgh Medical Center · USChildren's Hospital of Pittsburgh · USUniversity of Alabama at Birmingham · US

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
UAB CF Research and Translation Core CenterP30DK072482 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Susan Elizabeth Birket · 2007 to 2026
$23.0M
Translational StudiesP30DK072506 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FRIZZELL, RAYMOND A · 2005 to 2017
$12.5M
Viral Persistence and PathogenesisT32AI049820 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DELUCA, NEAL A. · 2001 to 2024
$5.5M
Pittsburgh Training Grant in Pediatric Pulmonary MedicineT32HL129949 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Juan Carlos Celedon · 2016 to 2026
$2.9M
Dysbiosis Impact on Lung Disease in HIV (DImpL) StudyR01HL138630 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI METHE, BARBARA, MORRIS, ALISON · 2017 to 2020
$2.3M
Viral-bacterial co-infections in the lungR01HL123771 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BOMBERGER, JENNIFER MELINDA · 2015 to 2018
$1.5M
Nebulized Nitrite as a Novel Antimicrobial Therapy in Cystic FibrosisK23HL131930 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZEMKE, ANNA CHRISTINE · 2016 to 2020
$865k
Impact of virome on microbial communities in the respiratory tractR61HL137077 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BOMBERGER, JENNIFER MELINDA · 2017 to 2018
$524k
Determination of immunogenic microbiota in the lung: leveraging the Lung HIV Microbiome ProjectR21HL143091 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI METHE, BARBARA, MORRIS, ALISON · 2018 to 2019
$235k
NCATS NIH HHS UL1 TR000005NHLBI NIH HHS K23 HL131930NHLBI NIH HHS R01 HL123771NHLBI NIH HHS R01 HL138630NHLBI NIH HHS R21 HL143091NHLBI NIH HHS R61 HL137077NHLBI NIH HHS T32 HL129949NIAID NIH HHS T32 AI049820NIDDK NIH HHS P30 DK072482NIDDK NIH HHS P30 DK072506
6 · The paper itself

Abstract

Chronic rhinosinusitis (CRS) is a common, yet underreported and understudied manifestation of upper respiratory disease in people with cystic fibrosis (CF). Recently developed standard of care guidelines for the management of CF CRS suggest treatment of upper airway disease may ameliorate lower airway disease. We sought to determine whether changes to sinus microbial community diversity and specific taxa known to cause CF lung disease are associated with increased respiratory disease and inflammation. We performed 16S rRNA gene sequencing, supplemented with cytokine analyses, microscopy, and bacterial culturing, on samples from the sinuses of 27 adults with CF CRS. At each study visit, participants underwent endoscopic paranasal sinus sampling and clinical evaluation. We identified key drivers of microbial community composition and evaluated relationships between diversity and taxa with disease outcomes and inflammation. Sinus community diversity was low, and the composition was unstable, with many participants exhibiting alternating dominance between Pseudomonas aeruginosa and staphylococci over time. Despite a tendency for dominance by these two taxa, communities were highly individualized and shifted composition during exacerbation of sinus disease symptoms. Exacerbations were also associated with communities dominated by Staphylococcus spp. Reduced microbial community diversity was linked to worse sinus disease and the inflammatory status of the sinuses (including increased interleukin-1β [IL-1β]). Increased IL-1β was also linked to worse sinus endoscopic appearance, and other cytokines were linked to microbial community dynamics. Our work revealed previously unknown instability of sinus microbial communities and a link between inflammation, lack of microbial community diversity, and worse sinus disease.

Indexed as

Cystic FibrosisMicrobiotaSinusitisAdultChronic DiseaseCystic Fibrosis Transmembrane Conductance RegulatorHumansInflammationInterleukin-1betaRNA, Ribosomal, 16SStaphylococcusCystic Fibrosis Transmembrane Conductance RegulatorInterleukin-1betaRNA, Ribosomal, 16Schronic rhinosinusitiscystic fibrosisinflammationmicrobiotapolymicrobialPseudomonas aeruginosarespiratory pathogenssinusStaphylococcus

Identifiers

PMID36094193
PMCPMC9603634
OpenAlexW4295279233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.